FNAM (Evolutionary Genomics) EV-to-OCF: -7.81 (As of Jul. 13, 2026)


FNAM Evolutionary Genomics Inc FNAM
31 GF Score
Price $0.00
View Full Analysis

What is Evolutionary Genomics EV-to-OCF?

Evolutionary Genomics FNAM 31 EV-to-OCF is -7.81 as of Jul. 13, 2026. GuruFocus rates FNAM with a GF Score™ of 31/100.

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Evolutionary Genomics's Enterprise Value is $5.01 Mil. Evolutionary Genomics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2022 was $-0.64 Mil. Therefore, Evolutionary Genomics's EV-to-OCF for today is -7.81.

The historical rank and industry rank for Evolutionary Genomics's EV-to-OCF or its related term are showing as below:

FNAM's EV-to-OCF is not ranked *
in the Biotechnology industry.
Industry Median: -3.51
* Ranked among companies with meaningful EV-to-OCF only.

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-13), Evolutionary Genomics's stock price is $0.0002. Evolutionary Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $-0.340. Therefore, Evolutionary Genomics's PE Ratio (TTM) for today is At Loss.

Evolutionary Genomics  (OTCPK:FNAM) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Evolutionary Genomics's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0002/-0.340
=At Loss

Evolutionary Genomics's share price for today is $0.0002.
Evolutionary Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.340.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Evolutionary Genomics EV-to-OCF Related Terms

Evolutionary Genomics EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Evolutionary Genomics's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolutionary Genomics EV-to-OCF Chart

Evolutionary Genomics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.66 -15.47 -4.24 -5.79 -15.07

Evolutionary Genomics Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FNAM
31GF Score
Evolutionary Genomics Inc FNAM
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolutionary Genomics EV-to-OCF Calculation

Evolutionary Genomics's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=5.007/-0.641
=-7.81

Evolutionary Genomics's current Enterprise Value is $5.01 Mil.
Evolutionary Genomics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-OCF →
What does a EV-to-OCF of -7.81 mean?
Evolutionary Genomics (FNAM) has a EV-to-OCF of -7.81 as of Jul. 13, 2026.
Is Evolutionary Genomics' EV-to-OCF too high?
Evolutionary Genomics' current EV-to-OCF is -7.81. Overall, Evolutionary Genomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Evolutionary Genomics' EV-to-OCF compare to BXRX and GNCA?
Evolutionary Genomics' EV-to-OCF of -7.81 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Evolutionary Genomics's current EV-to-OCF is -7.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolutionary Genomics stock overvalued right now?
Evolutionary Genomics (FNAM) has a current EV-to-OCF of -7.81. The current EV-to-OCF is -7.81. Evolutionary Genomics' overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Evolutionary Genomics (FNAM), the current EV-to-OCF is -7.81 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evolutionary Genomics Business Description

Address 4220 Morning Star Drive, Castle Rock, CO, USA, 80108
Evolutionary Genomics Inc is involved in the development of a technology platform, the Adapted Traits Platform (ATP), to identify commercially valuable genes that control important traits in animals and plants. It uses the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. The company's platform identifies key genes that have changed successfully to impart new or improved traits. Its primary source of revenue had been contract services revenue for research performed by it on behalf of other commercial entities and grant income received from governmental agencies, industry associations and grant-making foundations for research performed.
31GF Score

Get the complete analysis for FNAM

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price